DE19975062I1 - Pharmazeutische Zusammensetzungen die N-substituierte 3-Hydroxypyrid-2-on-oder-4-on-Derivate enthalten - Google Patents

Pharmazeutische Zusammensetzungen die N-substituierte 3-Hydroxypyrid-2-on-oder-4-on-Derivate enthalten

Info

Publication number
DE19975062I1
DE19975062I1 DE1999175062 DE19975062C DE19975062I1 DE 19975062 I1 DE19975062 I1 DE 19975062I1 DE 1999175062 DE1999175062 DE 1999175062 DE 19975062 C DE19975062 C DE 19975062C DE 19975062 I1 DE19975062 I1 DE 19975062I1
Authority
DE
Germany
Prior art keywords
hydroxypyrid
derivatives
substituted
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE1999175062
Other languages
German (de)
English (en)
Inventor
Jack Silver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAT RES DEV
National Research Development Corp UK
Original Assignee
NAT RES DEV
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAT RES DEV, National Research Development Corp UK filed Critical NAT RES DEV
Application granted granted Critical
Publication of DE19975062I1 publication Critical patent/DE19975062I1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
DE1999175062 1982-03-24 1983-03-24 Pharmazeutische Zusammensetzungen die N-substituierte 3-Hydroxypyrid-2-on-oder-4-on-Derivate enthalten Pending DE19975062I1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8208608 1982-03-24

Publications (1)

Publication Number Publication Date
DE19975062I1 true DE19975062I1 (de) 2003-09-04

Family

ID=10529232

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1999175062 Pending DE19975062I1 (de) 1982-03-24 1983-03-24 Pharmazeutische Zusammensetzungen die N-substituierte 3-Hydroxypyrid-2-on-oder-4-on-Derivate enthalten
DE8383301659T Expired DE3367849D1 (en) 1982-03-24 1983-03-24 Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8383301659T Expired DE3367849D1 (en) 1982-03-24 1983-03-24 Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives

Country Status (8)

Country Link
US (1) US4840958A (cg-RX-API-DMAC7.html)
EP (1) EP0093498B1 (cg-RX-API-DMAC7.html)
JP (3) JPS58174319A (cg-RX-API-DMAC7.html)
CY (1) CY1502A (cg-RX-API-DMAC7.html)
DE (2) DE19975062I1 (cg-RX-API-DMAC7.html)
GR (1) GR78491B (cg-RX-API-DMAC7.html)
HK (1) HK6190A (cg-RX-API-DMAC7.html)
NL (1) NL990031I2 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
EP0305646B1 (en) * 1983-03-24 1996-11-13 Btg International Limited 3-Hydroxypyrid-4-ones and pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325494D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
EP0335745A1 (en) * 1988-03-31 1989-10-04 The Royal Free Hospital School Of Medicine Process for producing pyrid-4-ones
GB8910521D0 (en) * 1989-05-08 1989-06-21 Nat Res Dev The stabilization of organic compounds
US5298525A (en) * 1992-11-23 1994-03-29 University Technologies International, Inc. Diabetes prevention and treatment
US6046219A (en) * 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5849587A (en) * 1995-06-09 1998-12-15 Cornell Research Foundation, Inc. Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
EP0833627B1 (en) 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
US6004986A (en) * 1997-05-08 1999-12-21 The University Of Virginia Patent Foundation Method for treating cerebral vasospasm and cerebral ischemia using iron chelators and pharmaceutical compositions therefor
US6767741B1 (en) * 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
IL135884A (en) * 2000-04-30 2005-08-31 Yissum Res Dev Co Method for measuring non-transferrin bound iron
CA2421410C (en) * 2000-09-19 2009-11-10 Vitra Pharmaceuticals Limited Iron compositions
US6426418B1 (en) 2001-11-02 2002-07-30 Apotex, Inc. Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
WO2004040252A2 (en) 2002-10-30 2004-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Molecules and methods using same for measuring non-transferrin bound iron
US8058442B2 (en) 2002-11-07 2011-11-15 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
CA2488034C (en) * 2004-11-19 2009-10-06 Apotex Inc. Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
US9309199B2 (en) * 2010-03-04 2016-04-12 Merck Sharp & Dohme Corp. Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
GB201007209D0 (en) 2010-04-29 2010-06-16 King S College London Compound
WO2012137202A1 (en) 2011-04-05 2012-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
JP7113009B2 (ja) 2016-11-07 2022-08-04 アービュタス バイオファーマ コーポレイション 置換ピリジノン含有三環式化合物およびそれを使用する方法
TWI801517B (zh) 2018-03-12 2023-05-11 加拿大商愛彼特生物製藥公司 經取代的2-吡啶酮三環化合物、其類似物及其使用方法
TW202010499A (zh) 2018-04-12 2020-03-16 加拿大商愛彼特生物製藥公司 經取代的吡啶酮之三環化合物的製備方法

Also Published As

Publication number Publication date
JPH0757749B2 (ja) 1995-06-21
NL990031I1 (nl) 1999-12-01
JPH0680636A (ja) 1994-03-22
EP0093498A3 (en) 1984-07-11
EP0093498A2 (en) 1983-11-09
JPS58174318A (ja) 1983-10-13
JPH0460987B2 (cg-RX-API-DMAC7.html) 1992-09-29
US4840958A (en) 1989-06-20
EP0093498B1 (en) 1986-11-26
JPS58174319A (ja) 1983-10-13
GR78491B (cg-RX-API-DMAC7.html) 1984-09-27
CY1502A (en) 1990-08-03
HK6190A (en) 1990-02-02
NL990031I2 (nl) 2000-04-03
JPH0515693B2 (cg-RX-API-DMAC7.html) 1993-03-02
DE3367849D1 (en) 1987-01-15

Similar Documents

Publication Publication Date Title
IT8149407A0 (it) Derivato di amminoalchilfurano procedimento per produrlo e composizione farmaceutica che lo contiene
FI922364A7 (fi) Farmaseuttiset koostumukset
DK68392D0 (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
SE8801813D0 (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
PT73686A (pt) Pharmaceutical formulation
NL990031I2 (nl) Farmaceutisch preparen die N-gesubstitueerde 3-hydroxypyrid-2-on of 4-onderrivaten bevatten.
MY8600029A (en) 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing themn
PH22726A (en) Pharmaceutical composition containing oxicam derivatives
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
IT1162879B (it) Composizioni farmaceutiche
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
MX9203628A (es) Compuestos florados de benciltriazol y composiciones farmaceuticas que los contienen.
IT1207106B (it) Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale
NZ196640A (en) Pyrimidone derivatives; pharmaceutical compositions
ATE36455T1 (de) Pharmazeutische zusammensetzungen.
MX11584A (es) Composiciones farmaceuticas
IT1208432B (it) Composizioni farmaceutiche
IT8249072A0 (it) Composizioni farmaceutiche
IL70273A (en) N-(substituted alkyl)acridanone-2-thiazole-2-yl-hydrazone derivatives,their manufacture and pharmaceutical compositions containing them
FR2618676B1 (fr) Compositions pharmaceutiques antivirales
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
ATE7360T1 (de) Zwei-beta-lactam-derivate enthaltende pharmazeutische zusammensetzungen.
IT8221553A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.